Anesthesia Drugs Market
According to Intent Market Research, the Anesthesia Drugs Market is expected to grow from USD 9.7 Billion in 2023 at a CAGR of 6.1% to touch USD 14.7 Billion by 2030. The Anesthesia Drugs Market is dominated by key players such as AbbVie Inc., Baxter International Inc., Cardinal Health, Inc., Drägerwerk AG & Co. KGaA, F. Hoffmann-La Roche Ltd., Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc., Medtronic PLC, Mylan N.V. (Viatris Inc.), Novartis AG, Sandoz (A Novartis Division) and Zydus Cadila.